|
1
|
Zheng Z, Tian R and Wang P: Roles of KAI1
and nm23 in lymphangiogenesis and lymph metastasis of laryngeal
squamous cell carcinoma. World J Surg Oncol. 15:2112017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lovato A, Marioni G, Manzato E, Staffieri
C, Giacomelli L, Ralli G, Staffieri A and Blandamura S: Elderly
patients at higher risk of laryngeal carcinoma recurrence could be
identified by a panel of two biomarkers (nm23-H1 and CD105) and pN+
status. Eur Arch Otorhinolaryngol. 272:3417–3424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lionello M, Blandamura S, Lovato A,
Franchella S, Giacomelli L, Ottaviano G, Stellini E, Staffieri A
and Marioni G: A high nuclear nm23-H1 expression is associated with
a better prognosis in elderly patients with laryngeal carcinoma.
Acta Otolaryngol. 133:874–880. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du P, Xu B, Zhang D, Shao Y, Zheng X, Li
X, Xiong Y, Wu C and Jiang J: Hierarchical investigating the
predictive value of p53, COX2, EGFR, nm23 in the post-operative
patients with colorectal carcinoma. Oncotarget. 8:954–966.
2017.PubMed/NCBI
|
|
5
|
Perisa MM, Sarcevic B, Troselj KG, Grsic
K, Sitic S and Seiwerth S: Expression of nm23-H1 and COX-2 in
thyroid papillary carcinoma and microcarcinoma. Oncol Lett.
13:3547–3555. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geng QQ, Li Y, Tang CH, Li EX, Wu YY and
Zhang GJ: Expression and clinical significance of vascular
endothelial growth factor-C and nm23-H1 in stage II and III
colorectal carcinomas. Zhonghua Zhong Liu Za Zhi. 35:439–444.
2013.(In Chinese). PubMed/NCBI
|
|
7
|
Radović S, Dorić M, Hukić A, Babić M,
Kuskunović S and Spahović N: Immunohistochemical expression and
significance of NM23 suppressor protein in primary gastric
adenocarcinoma. Bosn J Basic Med Sci. 13:72–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lionello M, Blandamura S, Agostini M,
Staffieri C, Lovato A, Tealdo G, Favaretto N, Giacomelli L,
Loreggian L, Staffieri A, et al: A prognostic role for Nm23-H1 in
laryngeal carcinoma treated with postoperative radiotherapy: An
introductory investigation. Eur Arch Otorhinolaryngol. 270:197–203.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bozdogan O, Vargel I, Cavusoglu T,
Karabulut AA, Karahan G, Sayar N, Atasoy P and Yulug IG: Metastasis
suppressor proteins in cutaneous squamous cell carcinoma. Pathol
Res Pract. 212:608–615. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan C, Xu XH, Xu L, Sun M, Ni LH, Liu Y,
Ran F, Wang XL, Chen Z, Zhang K, et al: Low expression of nm23-H1
associates with poor survival of nasopharyngeal carcinoma patients:
A prisma-compliant meta-analysis. Medicine (Baltimore).
96:e71532017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang YF, Chang CJ, Chiu JH, Lin CP, Li WY,
Chang SY, Chu PY, Tai SK and Chen YJ: NM23-H1 expression of head
and neck squamous cell carcinoma in association with the response
to cisplatin treatment. Oncotarget. 5:7392–7405. 2014.PubMed/NCBI
|
|
12
|
Cubukcu E, Kanat O, Olmez Fatih O, Kabul
S, Canhoroz M, Avci N, Deligonul A, Hartavi M, Cubukcu S, Olmez F,
et al: Prognostic significance of estrogen receptor, progesterone
receptor, HER2/neu, Ki-67, and nm23 expression in patients with
invasive breast cancer. J BUON. 18:359–365. 2013.PubMed/NCBI
|
|
13
|
Marioni G, Ottaviano G, Lionello M, Lora
L, Lovato A, Staffieri C, Favaretto N, Giacomelli L, Stellini E,
Staffieri A, et al: Nm23-H1 nuclear expression is associated with a
more favourable prognosis in laryngeal carcinoma: Univariate and
multivariate analysis. Histopathology. 61:1057–1064. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang M, Tao Y, Liu Z, Huang H, Lao M,
Huang L and Zhu B: Meta-analysis of the relationship between NM23
expression to gastric cancer risk and clinical features. BioMed Res
Int. 2017:80471832017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He F, York JP, Burroughs SG, Qin L, Xia J,
Chen D, Quigley EM, Webb P, LeSage GD and Xia X: Recruited
metastasis suppressor NM23-H2 attenuates expression and activity of
peroxisome proliferator-activated receptor δ (PPARδ) in human
cholangiocarcinoma. Dig Liver Dis. 47:62–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han W, Zhang C, Cao FY, Cao F, Jiang L and
Ding HZ: Prognostic and clinicopathological value of NM23
expression in patients with breast cancer: A systematic review and
meta-analysis. Curr Probl Cancer. 41:80–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tong Y, Yung LY and Wong YH: Metastasis
suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic
transformation and tumorigenesis. Cancer Lett. 361:207–217. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu JW and Chu XQ: Correlation between
non-metastatic protein 23 expression and clinicopathological
features of colorectal cancer in Asians. Genet Mol Res.
14:15597–15608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shahebrahimi K, Madani SH, Fazaeli AR,
Khazaei S, Kanani M and Keshavarz A: Diagnostic value of CD56 and
nm23 markers in papillary thyroid carcinoma. Indian J Pathol
Microbiol. 56:2–5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang T, Chen BZ, Li DF, Wang HM, Lin XS,
Wei HF and Zeng YM: Reduced NM23 protein level correlates with
worse clinicopathologic features in colorectal cancers: A
meta-analysis of pooled data. Medicine (Baltimore). 95:e25892016.
View Article : Google Scholar : PubMed/NCBI
|
